Dr. Shirani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Nebraska Medical Center
988440 Nebraska Medical Center
Omaha, NE 68198
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Neuroimmunology & Multiple Sclerosis, 2017 - 2019
Washington University in St. LouisMaster of Science in Clinical Investigation, 2017 - 2019
University of Texas Southwestern Medical CenterResidency, Neurology, 2013 - 2017- University of Texas Southwestern Medical CenterInternship, Preliminary Year, 2013 - 2014
- University of British ColumbiaPost-Doctoral Fellowship, 2009 - 2013
Tehran University of Medical Sciences School of MedicineClass of 2005, MD
Certifications & Licensure
DC State Medical License 2024 - 2027
CA State Medical License 2024 - 2026
NE State Medical License Active through 2026
CO State Medical License 2024 - 2025
IA State Medical License 2021 - 2025
KS State Medical License 2024 - 2025
MD State Medical License 2024 - 2025- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Physicians Scientist Program Award University of Nebraska Medical Center, 2019-2021
- Clinician Scientist Development Award National Multiple Sclerosis Society (USA), 2017-2020
- Clinical Research Training Scholarship American Academy of Neurology, 2017-2019
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsRelative mortality and survival in multiple sclerosis: findings from British Columbia, CanadaElaine Kingwell, M. van der Kop, Yinshan Zhao, Afsaneh Shirani, Feng Zhu
Journal of Neurology, Neurosurgery, and Psychiatry. 2012-01-01 - 200 citationsAssociation Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple SclerosisAfsaneh Shirani, Yinshan Zhao, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell
JAMA. 2012-07-18 - 26 citationsAging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, Amber Salter, Gary Cutter
Therapeutic Advances in Neurological Disorders. 2020-10-28
Press Mentions
New Faculty Spotlight: Afsaneh Shirani, M.D.July 22nd, 2019
Diabetes Weight Loss Drugs Could Be Linked to Reduced Risk of MS, Study FindsApril 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
